<DOC>
	<DOCNO>NCT00604383</DOCNO>
	<brief_summary>This study test whether 32 milligram ( mg ) ruboxistaurin day three year reduce vision loss associate diabetic retinopathy .</brief_summary>
	<brief_title>Protein Kinase C ( PKC ) Inhibitor-Diabetic Retinopathy Phase 3 Study</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Ruboxistaurin</mesh_term>
	<criteria>Type 1 Type 2 diabetes mellitus 18 year old Meet specific requirement diabetic retinopathy Free severe chronically disable condition , except diabetes , diabetic retinopathy diabetic macular edema Hemoglobin A1c ( HbA1C ) â‰¤13.0 % History panretinal photocoagulation diabetic retinopathy , condition might affect progression diabetic retinopathy , unstable angina Investigators , site personnel directly affiliate study family Presence eye disorder may affect progression diabetic retinopathy cause vision loss Presence medical disorder , cancer , elevate laboratory measurement could represent safety risk study Women pregnant , breastfeeding , intend become pregnant , sexually active without use acceptable method birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>